Scarica l'app Stockscreener
594.89
0.33%
1.97
Dopo l'orario di chiusura:
593.41
-1.48
-0.25%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché META Giù?
Forum
Previsione
Precedente Chiudi:
$592.92
Aprire:
$598.74
Volume 24 ore:
12.53M
Relative Volume:
0.85
Capitalizzazione di mercato:
$1.50T
Reddito:
$200.97B
Utile/perdita netta:
$60.46B
Rapporto P/E:
25.32
EPS:
23.4909
Flusso di cassa netto:
$46.11B
1 W Prestazione:
-3.38%
1M Prestazione:
-9.00%
6M Prestazione:
-20.57%
1 anno Prestazione:
-5.02%
Intervallo 1D:
$593.40
$603.67
Intervallo di 1 settimana:
$587.25
$613.00
Portata 52W:
$479.80
$796.25
Meta Platforms Inc Stock (META) Company Profile
Nome
Meta Platforms Inc
Settore
Industria
Telefono
650-543-4800
Indirizzo
1 META WAY, MENLO PARK
Compare META vs GOOGL, GOOG, SPOT, DASH
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
META
Meta Platforms Inc
|
594.89 | 1.50T | 200.97B | 60.46B | 46.11B | 23.49 |
GOOGL
Alphabet Inc
|
290.93 | 3.51T | 403.06B | 132.17B | 73.27B | 10.81 |
GOOG
Alphabet Inc
|
289.59 | 3.50T | 403.06B | 132.17B | 73.27B | 10.81 |
SPOT
Spotify Technology S A
|
473.21 | 99.82B | 19.43B | 2.56B | 3.41B | 9.6489 |
DASH
Doordash Inc
|
152.92 | 67.22B | 13.72B | 932.00M | 1.83B | 2.1265 |
Meta Platforms Inc Stock (META) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-03-05 | Downgrade | Arete | Buy → Neutral |
| 2026-03-05 | Aggiornamento | Erste Group | Hold → Buy |
| 2026-02-23 | Reiterato | Wells Fargo | Overweight |
| 2026-01-29 | Reiterato | Canaccord Genuity | Buy |
| 2026-01-29 | Reiterato | Cantor Fitzgerald | Overweight |
| 2026-01-29 | Reiterato | Deutsche Bank | Buy |
| 2026-01-29 | Reiterato | Evercore ISI | Outperform |
| 2026-01-29 | Reiterato | Guggenheim | Buy |
| 2026-01-29 | Reiterato | JP Morgan | Overweight |
| 2026-01-29 | Reiterato | Jefferies | Buy |
| 2026-01-29 | Reiterato | KeyBanc Capital Markets | Overweight |
| 2026-01-29 | Reiterato | Mizuho | Outperform |
| 2026-01-29 | Reiterato | Monness Crespi & Hardt | Buy |
| 2026-01-29 | Reiterato | Morgan Stanley | Overweight |
| 2026-01-29 | Reiterato | Piper Sandler | Overweight |
| 2026-01-29 | Reiterato | Pivotal Research Group | Buy |
| 2026-01-29 | Reiterato | Robert W. Baird | Outperform |
| 2026-01-29 | Reiterato | Roth Capital | Buy |
| 2026-01-29 | Reiterato | Stifel | Buy |
| 2026-01-29 | Reiterato | UBS | Buy |
| 2026-01-29 | Reiterato | Wedbush | Outperform |
| 2026-01-29 | Reiterato | Wells Fargo | Overweight |
| 2026-01-29 | Reiterato | Wolfe Research | Outperform |
| 2026-01-26 | Reiterato | KeyBanc Capital Markets | Overweight |
| 2026-01-26 | Reiterato | Raymond James | Strong Buy |
| 2026-01-26 | Aggiornamento | Rothschild & Co Redburn | Neutral → Buy |
| 2026-01-23 | Reiterato | Stifel | Buy |
| 2026-01-13 | Reiterato | TD Cowen | Buy |
| 2026-01-12 | Reiterato | Wells Fargo | Overweight |
| 2026-01-08 | Reiterato | Cantor Fitzgerald | Overweight |
| 2026-01-08 | Reiterato | Guggenheim | Buy |
| 2025-12-04 | Aggiornamento | Arete | Neutral → Buy |
| 2025-11-24 | Iniziato | BNP Paribas Exane | Outperform |
| 2025-11-10 | Downgrade | Erste Group | Buy → Hold |
| 2025-10-30 | Reiterato | Barclays | Overweight |
| 2025-10-30 | Reiterato | Bernstein | Outperform |
| 2025-10-30 | Reiterato | BofA Securities | Buy |
| 2025-10-30 | Reiterato | Citigroup | Buy |
| 2025-10-30 | Reiterato | JP Morgan | Overweight |
| 2025-10-30 | Reiterato | Jefferies | Buy |
| 2025-10-30 | Reiterato | Mizuho | Outperform |
| 2025-10-30 | Reiterato | Monness Crespi & Hardt | Buy |
| 2025-10-30 | Downgrade | Oppenheimer | Outperform → Perform |
| 2025-10-30 | Reiterato | Piper Sandler | Overweight |
| 2025-10-30 | Reiterato | Stifel | Buy |
| 2025-10-30 | Downgrade | The Benchmark Company | Buy → Hold |
| 2025-10-20 | Reiterato | Oppenheimer | Outperform |
| 2025-10-07 | Reiterato | Wells Fargo | Overweight |
| 2025-09-30 | Iniziato | Mizuho | Outperform |
| 2025-07-31 | Reiterato | BMO Capital Markets | Market Perform |
| 2025-07-31 | Reiterato | Bernstein | Outperform |
| 2025-07-31 | Reiterato | BofA Securities | Buy |
| 2025-07-31 | Reiterato | Citigroup | Buy |
| 2025-07-31 | Reiterato | Citizens JMP | Mkt Outperform |
| 2025-07-31 | Reiterato | JP Morgan | Overweight |
| 2025-07-31 | Reiterato | KeyBanc Capital Markets | Overweight |
| 2025-07-31 | Reiterato | Monness Crespi & Hardt | Buy |
| 2025-07-31 | Reiterato | Morgan Stanley | Overweight |
| 2025-07-31 | Reiterato | Oppenheimer | Outperform |
| 2025-07-31 | Reiterato | Pivotal Research Group | Buy |
| 2025-07-31 | Reiterato | TD Cowen | Buy |
| 2025-07-31 | Reiterato | UBS | Buy |
| 2025-07-31 | Reiterato | Wedbush | Outperform |
| 2025-07-31 | Reiterato | Wells Fargo | Overweight |
| 2025-07-28 | Reiterato | Guggenheim | Buy |
| 2025-07-16 | Reiterato | Canaccord Genuity | Buy |
| 2025-07-03 | Aggiornamento | Needham | Underperform → Hold |
| 2025-06-26 | Reiterato | UBS | Buy |
| 2025-06-24 | Reiterato | Citigroup | Buy |
| 2025-05-01 | Reiterato | BofA Securities | Buy |
| 2025-05-01 | Reiterato | Citigroup | Buy |
| 2025-05-01 | Reiterato | Evercore ISI | Outperform |
| 2025-05-01 | Reiterato | Goldman | Buy |
| 2025-05-01 | Reiterato | Guggenheim | Buy |
| 2025-05-01 | Reiterato | JP Morgan | Overweight |
| 2025-05-01 | Reiterato | KeyBanc Capital Markets | Overweight |
| 2025-05-01 | Reiterato | MoffettNathanson | Buy |
| 2025-05-01 | Reiterato | Monness Crespi & Hardt | Buy |
| 2025-05-01 | Reiterato | Morgan Stanley | Overweight |
| 2025-05-01 | Reiterato | Oppenheimer | Outperform |
| 2025-05-01 | Reiterato | Piper Sandler | Overweight |
| 2025-05-01 | Reiterato | Pivotal Research Group | Buy |
| 2025-05-01 | Reiterato | Raymond James | Strong Buy |
| 2025-05-01 | Reiterato | Rosenblatt | Buy |
| 2025-05-01 | Reiterato | Roth Capital | Buy |
| 2025-05-01 | Reiterato | Stifel | Buy |
| 2025-05-01 | Reiterato | Truist | Buy |
| 2025-05-01 | Reiterato | UBS | Buy |
| 2025-05-01 | Reiterato | Wedbush | Outperform |
| 2025-04-14 | Reiterato | Citigroup | Buy |
| 2025-04-10 | Reiterato | Piper Sandler | Overweight |
| 2025-01-30 | Aggiornamento | The Benchmark Company | Hold → Buy |
| 2025-01-23 | Reiterato | BofA Securities | Buy |
| 2025-01-22 | Reiterato | Cantor Fitzgerald | Overweight |
| 2025-01-06 | Reiterato | Jefferies | Buy |
| 2025-01-03 | Reiterato | Wolfe Research | Outperform |
| 2024-10-31 | Reiterato | Monness Crespi & Hardt | Buy |
| 2024-10-31 | Reiterato | Pivotal Research Group | Buy |
| 2024-10-11 | Iniziato | Scotiabank | Sector Perform |
| 2024-10-09 | Reiterato | Cantor Fitzgerald | Overweight |
| 2024-10-01 | Iniziato | Pivotal Research Group | Buy |
| 2024-09-30 | Reiterato | Monness Crespi & Hardt | Buy |
| 2024-09-10 | Iniziato | DA Davidson | Buy |
| 2024-09-05 | Iniziato | Cantor Fitzgerald | Overweight |
| 2024-08-01 | Reiterato | BofA Securities | Buy |
| 2024-07-19 | Reiterato | Oppenheimer | Outperform |
| 2024-07-16 | Iniziato | Wolfe Research | Outperform |
| 2024-07-10 | Reiterato | TD Cowen | Buy |
| 2024-07-08 | Reiterato | Wells Fargo | Overweight |
| 2024-07-01 | Reiterato | Raymond James | Strong Buy |
| 2024-06-12 | Reiterato | BMO Capital Markets | Market Perform |
| 2024-05-02 | Iniziato | Exane BNP Paribas | Underperform |
| 2024-04-25 | Reiterato | Oppenheimer | Outperform |
| 2024-04-15 | Reiterato | Citigroup | Buy |
| 2024-04-11 | Reiterato | Piper Sandler | Overweight |
| 2024-04-08 | Reiterato | Oppenheimer | Outperform |
| 2024-04-04 | Reiterato | Jefferies | Buy |
| 2024-02-02 | Reiterato | Guggenheim | Buy |
| 2024-02-02 | Reiterato | JMP Securities | Mkt Outperform |
| 2024-02-02 | Reiterato | JP Morgan | Overweight |
| 2024-02-02 | Reiterato | KeyBanc Capital Markets | Overweight |
| 2024-02-02 | Reiterato | Mizuho | Buy |
| 2024-02-02 | Reiterato | Monness Crespi & Hardt | Buy |
| 2024-02-02 | Reiterato | Morgan Stanley | Overweight |
| 2024-02-02 | Reiterato | Oppenheimer | Outperform |
| 2024-02-02 | Reiterato | Piper Sandler | Overweight |
| 2024-02-02 | Reiterato | ROTH MKM | Buy |
| 2024-02-02 | Reiterato | Raymond James | Strong Buy |
| 2024-02-02 | Reiterato | Robert W. Baird | Outperform |
| 2024-02-02 | Reiterato | Seaport Research Partners | Buy |
| 2024-02-02 | Reiterato | Stifel | Buy |
| 2024-02-02 | Reiterato | Susquehanna | Positive |
| 2024-02-02 | Reiterato | TD Cowen | Outperform |
| 2024-02-02 | Reiterato | UBS | Buy |
| 2024-02-02 | Reiterato | Wedbush | Outperform |
| 2024-02-02 | Reiterato | Wells Fargo | Overweight |
| 2024-02-02 | Reiterato | Wolfe Research | Outperform |
| 2024-01-23 | Reiterato | Citigroup | Buy |
| 2024-01-17 | Reiterato | Piper Sandler | Overweight |
| 2024-01-17 | Reiterato | Wells Fargo | Overweight |
| 2024-01-09 | Iniziato | BMO Capital Markets | Market Perform |
| 2023-12-20 | Ripresa | Raymond James | Strong Buy |
| 2023-10-24 | Iniziato | Seaport Research Partners | Buy |
| 2023-08-22 | Iniziato | Wedbush | Outperform |
| 2023-08-01 | Reiterato | Argus | Buy |
| 2023-07-28 | Aggiornamento | China Renaissance | Hold → Buy |
| 2023-07-27 | Aggiornamento | HSBC Securities | Reduce → Hold |
| 2023-07-27 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2023-07-25 | Reiterato | Mizuho | Buy |
| 2023-07-25 | Aggiornamento | New Street | Neutral → Buy |
| 2023-07-19 | Reiterato | Jefferies | Buy |
| 2023-07-19 | Reiterato | Truist | Buy |
| 2023-07-17 | Reiterato | Credit Suisse | Outperform |
| 2023-07-17 | Reiterato | Goldman | Buy |
| 2023-07-17 | Reiterato | JMP Securities | Mkt Outperform |
| 2023-07-13 | Aggiornamento | TD Cowen | Market Perform → Outperform |
| 2023-07-12 | Reiterato | Deutsche Bank | Buy |
| 2023-06-08 | Iniziato | Wells Fargo | Equal Weight |
| 2023-05-15 | Aggiornamento | Loop Capital | Hold → Buy |
| 2023-04-27 | Reiterato | Credit Suisse | Outperform |
| 2023-04-27 | Reiterato | Deutsche Bank | Buy |
| 2023-04-27 | Reiterato | Evercore ISI | Outperform |
| 2023-04-27 | Reiterato | Goldman | Buy |
| 2023-04-27 | Reiterato | Guggenheim | Buy |
| 2023-04-27 | Reiterato | JMP Securities | Mkt Outperform |
| 2023-04-27 | Reiterato | JP Morgan | Overweight |
| 2023-04-27 | Reiterato | Mizuho | Buy |
| 2023-04-27 | Reiterato | Monness Crespi & Hardt | Buy |
| 2023-04-27 | Reiterato | Morgan Stanley | Overweight |
| 2023-04-27 | Reiterato | Oppenheimer | Outperform |
| 2023-04-27 | Reiterato | Piper Sandler | Overweight |
| 2023-04-27 | Reiterato | RBC Capital Mkts | Outperform |
| 2023-04-27 | Reiterato | Raymond James | Outperform |
| 2023-04-27 | Reiterato | Robert W. Baird | Outperform |
| 2023-04-27 | Reiterato | Rosenblatt | Buy |
| 2023-04-27 | Reiterato | Stifel | Buy |
| 2023-04-27 | Reiterato | TD Cowen | Market Perform |
| 2023-04-27 | Reiterato | Truist | Buy |
| 2023-04-27 | Reiterato | Wolfe Research | Outperform |
Mostra tutto
Meta Platforms Inc Borsa (META) Ultime notizie
Meta, Google found liable in landmark social media addiction trial - USA Today
Juries in California, New Mexico Rule Against Meta - Focus on the Family
Meta, Google Found Liable in Social Media Addiction Case - Bloomberg.com
Google And Meta's Fate Hangs In The Balance As Jury Signals Deadlock In Social Media Addiction Trial - Yahoo Finance UK
Here's What Could Send Nvidia Stock to New All-Time Highs - The Motley Fool
Meta links new executive stock options to $13 trillion valuation - AFR
Meta loses child safety case, hit with huge financial penalty - Mashable
Meta and YouTube found liable in landmark social media addiction trial - BBC
Meta knowingly misled children and teens about safety, NM jury finds - WBUR
Landmark case finds Meta, Google liable for addicting app design - Fast Company
Meta, Google Ordered to Pay $6 Million in Social Media Addiction Trial - KQED
Landmark L.A. jury verdict finds Instagram, YouTube were designed to addict kids - Los Angeles Times
Meta and Google Lose Bellwether Social Media Trial - Barron's
Jury finds Meta and YouTube negligent in landmark lawsuit on social media safety - NBC News
Meta and Google damaged girl’s mental health, landmark trial concludes - The Times
Los Angeles social media addiction trial: Jury finds Meta and YouTube liable, awards $3 million in damages - ABC7 San Francisco
US jury finds Meta, Alphabet liable in landmark social media addiction case - Al Jazeera
Facebook, Instagram parent company ordered to pay $375 million for endangering children - Baptist Press
Meta Lays Off 700 Employees, While Rewarding Top Executives - The New York Times
Meta and YouTube found negligent in landmark social media addiction trial - Axios
Meta Layoffs Shake Up Company as AI Reshapes Workforce - inc.com
Meta Platforms Just Unveiled Ambitious Plans to Grow Its Stock Price by 500% Over Five Years - The Globe and Mail
Meta, YouTube found liable for social media addiction in landmark trial - Politico
California jury finds Meta, Google liable for teen’s mental distress in landmark social media trial - CalMatters
Meta, YouTube found negligent in landmark social media addiction lawsuit - Yahoo Finance
Trump names Nvidia, Meta and Oracle CEOs to council that will influence AI policy - The Globe and Mail
Instagram and YouTube found liable in landmark social media addiction trial in California - PBS
Jury finds Meta and YouTube negligent in landmark social media addiction trial - Yahoo Finance
Jury finds Meta, Google liable in landmark social media addiction trial, awards more than $6M in damages - Fox Business
Arm Holdings stock rallies over 19% after unveiling AI chips with Meta Platforms as lead customer - Mint
Jury holds Meta and Google liable for role in young woman's mental health issuesOregon Public Broadcasting - Oregon Public Broadcasting - OPB
Meta and YouTube found liable in social media addiction trial - CNN
Jury orders Meta and Google to pay woman $6 million in social media addiction trial - NPR
Meta and Google found liable for negligence in the design of Instagram and YouTube - Daily Journal
Jury finds Meta and YouTube liable in landmark social media addiction trial - FOX 17 West Michigan News
Meta and YouTube Lose Landmark Social Media Trial - WSJ
Jury in Los Angeles finds Meta, YouTube negligent in social media addiction trial - CNBC
Meta, Google lose US case over social media harm to kids - Reuters
XGS inks partnership to advance Meta’s New Mexico geothermal plant - ESG Dive
US jury fines Meta in landmark child‑safety case - dw.com
Meta's $375MN Lawsuit Underscores the Importance of Customer Trust in Community Platforms - CX Today
Meta Takes a Swipe at Tesla With $9 Trillion Stock Goal in Half the Time - Barron's
Meta begins laying off hundreds of employees across five divisions - NBC News
Meta Will Pay You Thousands of Dollars to Post on Facebook—But There's a Catch - Yahoo Finance
Facebook Parent Company Meta Cuts Hundreds of Jobs Across Multiple Divisions - Fine Day 102.3
We like the message of Meta's new executive stock plan — plus, a war beneficiary stock - CNBC
What's next in social media legal battles after a New Mexico jury finds Meta platforms harm children - PBS
Meta cutting several hundred jobs across Reality Labs, Facebook and other departments - CNBC
Meta launches new initiative to support entrepreneurship, drive AI adoption - Yahoo Finance
Meta to offer stock options to retain top execs as jury orders $375M penalty in child endangerment case - Proactive Investors
Meta turns to AI to make shopping easier on Instagram and Facebook - TechCrunch
Meta Platforms Inc Azioni (META) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Meta Platforms Inc Azioni (META) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| KIMMITT ROBERT M | Director |
Mar 16 '26 |
Sale |
632.02 |
580 |
366,572 |
4,427 |
| Olivan Javier | Chief Operating Officer |
Mar 16 '26 |
Sale |
632.02 |
926 |
585,251 |
14,261 |
| Olivan Javier | Chief Operating Officer |
Mar 16 '26 |
Sale |
632.02 |
629 |
397,541 |
2,714 |
2.40%
2.73%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):